Skip to main content
    C

    Cardinal Health Inc (CAH)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $283.87
    +2.77 (+0.99%)

    Market Cap: $64.97B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cardinal Health Inc (CAH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Cardinal Health (CAH) trades at 23.7x trailing earnings and 0.3x sales. Its P/E of 23.7x is above its 5-year median of 15.5x. Its forward P/E is 21.7x. The median P/E across 10 similar companies is 16.2x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 9.2% higher over the next year. Its free cash flow yield is 7.4%.

    MultipleValue
    P/E (trailing)23.7x
    Forward P/E21.7x
    Price to sales0.3x
    EV/EBITDA18.8x
    Price to FCF13.4x
    EV/FCF14.2x
    PEG1.3
    FCF yield7.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 79.5% above 13.2x.

    MultipleCurrent5-year median10-year median
    P/E23.7x15.5x13.2x
    P/S0.3x0.1xN/A
    Medians of month-end values through Oct 2026: 49 to 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 9.0x in 2018 to 21.4x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$205.5021.4x0.2xN/A
    2024$118.2715.3x0.1xN/A
    2023$100.8014.7x0.1xN/A
    2022$76.8715.3x0.1xN/A
    2021$51.4910.6xN/A14.4x
    2020$53.569.1x0.1x8.0x
    2019$50.589.2x0.1x14.8x
    2018$44.609.0xN/A2.2x
    2017$61.2711.3x0.1x2.5x
    2016$71.9714.0x0.2x3.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CAH

    What is CAH's forward P/E ratio?

    Cardinal Health has a forward P/E ratio of 21.7x.

    Is CAH stock overvalued?

    GNG's valuation label for CAH is Fairly valued. Its P/E of 23.7x compares with a median of 16.2x across 10 similar companies.

    What is CAH's price to sales ratio?

    Cardinal Health has a price to sales ratio of 0.3x.

    What is Cardinal Health's average P/E ratio over 5 years?

    Cardinal Health's median P/E over the last 5 years is 15.5x, from 60 month-end values through Oct 2026.

    What is CAH's PEG ratio?

    Cardinal Health has a PEG ratio of 1.3.